logo
搜索
菜单

K的搜索结果

当前1/125页
排序: 最近更新
24.3: Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists 01:28 min
24.3: Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
24.2: Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists 01:27 min
24.2: Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
24.1: Pathophysiology of Vomiting 01:22 min
24.1: Pathophysiology of Vomiting
23.7: Drugs for Treatment of Crohn’s Disease in IBD Using Glucocorticoids 01:21 min
23.7: Drugs for Treatment of Crohn’s Disease in IBD Using Glucocorticoids
23.6: Drugs for Treatment of Crohn’s Disease in IBD Using Biologic Agents: Anti-TNF 01:24 min
23.6: Drugs for Treatment of Crohn’s Disease in IBD Using Biologic Agents: Anti-TNF
23.4: Drugs for Treatment of Ulcerative Colitis in IBD 01:29 min
23.4: Drugs for Treatment of Ulcerative Colitis in IBD
23.1: Chronic Bowel Disorders: Introduction 01:17 min
23.1: Chronic Bowel Disorders: Introduction
22.9: Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents 01:20 min
22.9: Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
22.8: Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents 01:17 min
22.8: Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
22.6: Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives 01:22 min
22.6: Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
22.4: Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists 01:28 min
22.4: Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
21.6: Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents 01:24 min
21.6: Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
21.5: Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids 01:31 min
21.5: Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
21.1: Pathophysiology of Peptic Ulcer Disease: Injurious Factors 01:22 min
21.1: Pathophysiology of Peptic Ulcer Disease: Injurious Factors
20.5: Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers 01:26 min
20.5: Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
20.2: Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors 01:28 min
20.2: Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
25.37: Tumor Immunotherapy 01:27 min
25.37: Tumor Immunotherapy
25.36: Tissue Transplantation 01:24 min
25.36: Tissue Transplantation
25.32: Immune Response Against Viral Pathogens 01:29 min
25.32: Immune Response Against Viral Pathogens
25.31: Defense Against Bacterial Pathogens 01:31 min
25.31: Defense Against Bacterial Pathogens
返回顶部